Tagged with M

Ireland Sorcha McKenna, Partner at McKinsey & Company in Ireland, discusses the current trends in the Irish healthcare and life sciences sector, the potential behind both tech and integrated care for the industry, as well as some of the biggest evolutions she has seen during her 14-year career with the company.…

Pharma Do phenomenons such as Brexit and the Trump election victory mean trouble for the pharma industry or are you more optimistic? Take the PharmaBoardroom poll on the pharma industry in 2017 and stay tuned for the results! Create your own user feedback survey

Mexico GM Gerardo Torres-Septién explains how Grupo Rasch has managed to grow during the last two years and showcases the added value of its solutions to help the pharmaceutical industry enhance its cost structure and efficiency ratios. Could you please give an update to our international audience about the operations and…

Philippines The election of maverick former mayor of Davao, Rodrigo Duterte to the Filipino presidency in May 2016 represented a dramatic departure from politics as usual and raised interesting questions about future health policy in south East Asia’s second most populous country. “A human approach to development that leaves no citizen…

Ireland Jim Curley, the CEO of Jones Engineering Group, details the company’s more than 125-year history in Ireland and in more recent times across the UK, mainland Europe and the Middle East. He gives an insight into how they have maintained their leadership role in the engineering contracting industry particularly in…

Philippines The Top 10 pharmaceutical companies in the Philippines by revenue. Unilab leads the way, followed by Pfizer and Abbot.

Philippines Basic Philippines country facts The Philippines is among the world’s fastest growing economies. The Philippines’ economic performance for 2016 was steady, with GDP up almost a whole percentage point on 2015. Most of the Philippines’ wealth is centred in the capital Manila, with other, more rural areas, significantly poorer. The…

Taiwan In an exclusive interview conducted on the 22nd of December 2016, Taiwan’s Minister of Health and Welfare Lin Tzou-yien discussed improving Taiwan’s National Health Insurance (NHI), ensuring that Taiwanese patients can access innovative treatments, and nurturing the development of Taiwan’s thriving R&D-driven pharmaceutical and biotech industries. Minister Lin, you became…

Mexico Juan Francisco Hernández, general manager of Latin America at Wockhardt, showcases the added value of the company to the entire region based on quality, safety and cost-effective medicines targeting diabetes, CNS and anti-infective areas. Could you introduce yourself to our international readers as well as the key activities and operations…

Ireland Aidan Meagher, Tax Partner & Irish Life Sciences Lead for EY Ireland, discusses EY’s extensive consulting work, including their efforts to promote entrepreneurship in Ireland, the changing landscape facing the medtech industry in the country as well as how Ireland can work to make itself an even more attractive destination…

Mexico María Teresa Lopez, managing director at Zimmer Biomet Mexico, discusses the medtech company’s strong commitment to Mexico as well as the high added value of its broad and innovative health solutions to enhance patients’ quality of life. Please introduce the main activities of Zimmer Biomet in Mexico and the Mexican…

Switzerland www.celonic.com CEO of Swiss biologics CDMO Celonic, Konstantin Matentzoglu, explains how the company attracts talented and experienced staff and what makes it the partner of choice in Switzerland and beyond. Celonic is in many ways more than a CDMO for biologics. What is the strategic focus of this company? “Our…